Thu, December 19, 2019
Wed, December 18, 2019
Tue, December 17, 2019
Mon, December 16, 2019
Fri, December 13, 2019
Thu, December 12, 2019
Wed, December 11, 2019
Tue, December 10, 2019
Mon, December 9, 2019
Fri, December 6, 2019
Thu, December 5, 2019
Wed, December 4, 2019

Alethia Young Maintained (SRPT) at Buy with Increased Target to $211 on, Dec 13th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-211-on-dec-13th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Alethia Young of Cantor Fitzgerald, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $175 to $211 on, Dec 13th, 2019.

Alethia has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Alethia's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Alethia


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $167 on, Monday, November 18th, 2019
  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $181 on, Tuesday, August 20th, 2019

Publication Contributing Sources